South Korean pharmaceutical company Green Cross said Tuesday that it won a 60-million-dollar order to supply chickenpox vaccines to the Pan-American Health Organization or PAHO.
 
As an international public health agency under the World Health Organization, PAHO is known to be one of the world’s largest vaccine consumers along with UNICEF.
 
Green Cross said that its order accounts for 66 percent of the total amount of chickenpox vaccines PAHO will purchase. It will deliver the vaccines to Latin American countries over a stretch of two years from this year through the end of next year.
 
Green Cross President Huh Eun-chul said that the order has reconfirmed his company's status in the global market, promising that his company will work to boost international public health through vaccine supply.
 
The South Korean pharmaceutical firm developed the world’s second chickenpox vaccine in 1993.